|
Online edition of India's National Newspaper Monday, August 06, 2001 |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home |
|
Opinion
| Previous
| Next
Fluid genome - a paradigm shift
Debashis Banerji & Mihir Shah
THE SEQUENCING of the human genome was completed in February this
year. This was a truly historic event. Even more so because its
findings were quite different from those anticipated by the large
body of scientists working on the project. Indeed, it appears to
have propelled nothing less than a Kuhnian scientific revolution,
amounting to a decisive shift in the way we look at life and its
constituent elements.
The Human Genome Project (HGP) finally overthrows genetic
determinism, the theory that there are simple one-to-one
relationships between genes and characteristics of human beings.
This has been the presumption underlying the use of recombinant-
DNA technology by genetic engineers over the last 20 years. They
hunt for genes that cause problems and try to insert new, more
desirable genes to engineer ``better'' organisms. This entire
enterprise has been brought into question by the HGP which
supports a more complex and nuanced understanding of the way
genes work, that was all along being advocated by molecular
biologists opposed to genetic engineering. Announcing the
findings of the HGP, Mr. Craig Venter, President Celera
Corporation and one of the two most important scientists in the
effort to map the human genome, put it very bluntly: ``In
everyday language the talk is of a gene for this and a gene for
that. We are now finding that that is rarely so. The number of
genes that work in that way can almost be counted on your
fingers. The notion that one gene equals one disease, or that one
gene produces one key protein, is flying out of the window''.
Genetic engineering was based on a number of assumptions, now
decisively overthrown by the HGP. It was assumed that each gene
codes for a single protein molecule, adding a unique trait to the
behaviour of the organism (genes govern events in a cell by
creating different proteins). In a closed, one-way, linear causal
pathway, proteins are encoded by DNA and, therefore, DNA may be
said to encode function. Each gene is an independent unit of
information. The environment acts as a trigger to activate pre-
set programmes in DNA. It was also assumed that genes are stable,
being passed on unchanged to the next generation.
In fact, for relatively simple diseases, such as muscular
dystrophy, the one gene-one disease model appears to work very
well. Unfortunately, however, this is true for only two per cent
of all known diseases. In all other cases, including cancer,
heart disease and manic depression (the most common targets of
the genetic engineers), causation is found to be much more
complex. Many genes interacting with each other appear to play a
role. Also, an array of signals, including nutrient supply,
hormones and electrical signals from other cells, which form the
cellular environment, critically influence the course of these
diseases. What is more, all of these reflect the external
environment of the organism as a whole. Since each human being
has a unique genetic background, mutations in specific genes that
produce disease in one human body may not do so in another. Also,
since many genes appear to be involved in most diseases, the
effect of each specific gene is small. Thus, more importance
comes to be attached to factors such as the initial conditions
surrounding the development history of the individual.
The new fluid or dynamic genome view confirms what was known but
ignored by genocentric biology - that no gene works in isolation.
After all, genetic interaction has been part of graduate genetics
for over three decades now. The HGP also confirms what has been
known for years - that DNA sequences within one gene may be used
in coding many proteins. There is also no more doubt, if ever
there was any, that the control pathway of gene expression is not
closed and linear, but dynamic and circular. Changes in the
cellular environment are sensed or measured by regulatory
networks of proteins that function inside each cell. These
networks interpret such signals so that the cell can make an
appropriate response to these changes. Thus, protein networks
feed back information from the outside world to the DNA and
change patterns of gene expression in a context-dependent manner.
The crucial thing to note here is that these dynamic networks
have rules not specified by DNA. And this is an information
management system we are only now beginning to follow. Research
has started to shift in this direction. But it is clear that we
simply do not know enough about the response of living cells over
time to their manipulation by genetic engineering. We must also
remember that while molecular biology has made great advances in
describing the ``structural'' genes which affect properties of
bodily parts, knowledge about the genes that regulate the
activity of all the structural genes is still incomplete. All
told we are still unable to ascribe any function to as much as 95
per cent of all DNA. If we really want to understand and predict
the effect of the insertion of a foreign gene, we must surely
take this 95 per cent into account.
This collapse of genetic determinism suggests that genetic
engineering may not only be unpredictable or a failure, it may
also be dangerous. The fallacy of the assumption that each gene
just codes for one specific protein has time and again been
exposed by unanticipated metabolic changes following single gene
transfers. These changes have resulted in the appearance of very
sick and monstrous transgenic animals as also unexpected toxins
and allergens in transgenic plants. The lower survival capacity
of transgenic plants in environments different from those where
the plants were originally developed has undermined belief in
unidirectional control of gene expression. This may be the reason
why transgenic maize developed in the U.S. failed completely when
planted in the Philippines, or why the tomato FlavrSavr developed
in California did not grow well in Florida, and why Monsanto's
Bt-cotton crop did not work properly in Texas because it was
hotter, or in Australia because it was colder than where it was
developed. The belief that genomes are stable and unchanging has
led to an underestimation of the rapidity with which insects
develop resistance against built-in crop pesticides. A recent
study reveals how about 70 per cent of insects had become
resistant to the Bt-toxin produced by transgenic plants. An
additional problem is that genomes normally do not accept
intrusions by foreign genes. This ``species barrier'' is one of
the reasons why most gene insertion attempts fail. It also
contributes to the destabilisation of genes that have been
successfully inserted. Because of this it has been difficult to
create genetically stable transgenic organisms.
In 1989, 37 people died and thousands were permanently disabled
in the U.S. after they consumed a genetically engineered
nutritional supplement. Such a dangerous, unpredictable
technology needs careful regulation. But the experience in this
regard has not been a happy one either. Shocking facts were
revealed in a lawsuit filed by a coalition of public interest
groups, scientists and religious leaders led by the Alliance for
Biointegrity against the U.S. Food and Drug Administration (FDA)
in 1998. The FDA was forced to make public over 44,000 pages of
its files. These showed that the FDA had over-ruled many warnings
by its own scientists against declaring genetically engineered
foods safe. It is clear that corporate interests in biotechnology
based on the old genetics have investments of billions of dollars
in the pipeline. They have engaged in an unprecedented propaganda
blitz, playing on the health aspirations of people everywhere.
They are unlikely to allow state regulation unless powerful
coalitions of consumers and farmers compel the same. If pressure
of these groups grows, as in Europe, the companies will
inevitably zero in on Third World markets. This is where much
greater public awareness and vigilance is necessary.
As Mr. Richard Strohman, Professor Emeritus of Molecular and Cell
Biology at the University of California, Berkeley, says: ``We are
still in the dark ages about how organisms regulate their genomes
to produce adults... while the scientific inquiry must go on, the
inevitable technological applications, whether in medical centres
or in corn fields, must stop - until science assures us that we
may proceed while doing no harm.''
(The writers, a biologist and a social scientist respectively,
teach at the Baba Amte Centre for People's Empowerment, Madhya
Pradesh.)
Send this article to Friends by E-Mail
|
|
Section : Opinion Previous : Reinforce confidence Next : Higher judicial appointments - I | |
|
Front Page |
National |
Southern States |
Other States |
International |
Opinion |
Business |
Sport |
Entertainment |
Miscellaneous |
Features |
Classifieds |
Employment |
Index |
Home | |
|
Copyrights © 2001 The Hindu Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu |
|